PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
Angiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently publis...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1141 |
_version_ | 1797232232163704832 |
---|---|
author | S. A. Boytsov I. P. Kolos |
author_facet | S. A. Boytsov I. P. Kolos |
author_sort | S. A. Boytsov |
collection | DOAJ |
description | Angiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently published biggest international clinical studies, was performed in the article. Data demonstrate that ARA can be effectively and safely used in wide clinical practice for improvement of life quality and life prolongation in patients with HT. |
first_indexed | 2024-03-08T14:03:08Z |
format | Article |
id | doaj.art-75b89d21963742ceabdbf22b40457612 |
institution | Directory Open Access Journal |
issn | 1819-6446 2225-3653 |
language | English |
last_indexed | 2024-04-24T15:57:00Z |
publishDate | 2016-01-01 |
publisher | Столичная издательская компания |
record_format | Article |
series | Рациональная фармакотерапия в кардиологии |
spelling | doaj.art-75b89d21963742ceabdbf22b404576122024-04-01T07:43:32ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0144697510.20996/1819-6446-2008-4-4-69-751140PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPYS. A. Boytsov0I. P. Kolos1Russian Cardiology Research and Production Center of Rosmedtechnology, Tretya Cherepkovskaya ul. 15a, Moscow, 121552 RussiaRussian Cardiology Research and Production Center of Rosmedtechnology, Tretya Cherepkovskaya ul. 15a, Moscow, 121552 RussiaAngiotensin II receptor antagonists (ARA) established their position recently duet to new indications above arterial hypertension (HT). These are chronic heart failure, history of myocardial infarction, atrial fibrillation and metabolic syndrome. Analysis of evidence basis, including recently published biggest international clinical studies, was performed in the article. Data demonstrate that ARA can be effectively and safely used in wide clinical practice for improvement of life quality and life prolongation in patients with HT.https://www.rpcardio.online/jour/article/view/1141angiotensin ii receptor antagonistsace inhibitorsarterial hypertensionmyocardial infarctionatrial fibrillation |
spellingShingle | S. A. Boytsov I. P. Kolos PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Рациональная фармакотерапия в кардиологии angiotensin ii receptor antagonists ace inhibitors arterial hypertension myocardial infarction atrial fibrillation |
title | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY |
title_full | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY |
title_fullStr | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY |
title_full_unstemmed | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY |
title_short | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY |
title_sort | place of angiotensin ii receptor antagonists in arterial hypertension therapy |
topic | angiotensin ii receptor antagonists ace inhibitors arterial hypertension myocardial infarction atrial fibrillation |
url | https://www.rpcardio.online/jour/article/view/1141 |
work_keys_str_mv | AT saboytsov placeofangiotensiniireceptorantagonistsinarterialhypertensiontherapy AT ipkolos placeofangiotensiniireceptorantagonistsinarterialhypertensiontherapy |